Cargando…

ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis

OBJECTIVES: To investigate the effect of ACE inhibitors (ACEi) on the incidence of scleroderma renal crisis (SRC) when given prior to SRC in the prospectively collected cohort from the European Scleroderma Trial and Research Group (EUSTAR). METHODS: SSc patients without prior SRC and at least one fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bütikofer, Lukas, Varisco, Pierre A., Distler, O., Kowal-Bielecka, O., Allanore, Y., Riemekasten, G., Villiger, P. M., Adler, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093969/ https://www.ncbi.nlm.nih.gov/pubmed/32209135 http://dx.doi.org/10.1186/s13075-020-2141-2

Ejemplares similares

Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis
por: Dobrota, Rucsandra, et al.
Publicado: (2016)

Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database
por: Hoffmann-Vold, Anna-Maria, et al.
Publicado: (2021)

Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group
por: Adler, Sabine, et al.
Publicado: (2018)

Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: a DeSScipher/European Scleroderma Trials and Research group (EUSTAR) survey
por: Blagojevic, J., et al.
Publicado: (2019)

Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis
por: Becker, Mike, et al.
Publicado: (2019)

Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study
por: Jaeger, Veronika K., et al.
Publicado: (2016)

Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort
por: Wu, Wanlong, et al.
Publicado: (2019)

Scleroderma renal crisis: Case reports and update on critical issues
por: Zanatta, Elisabetta, et al.
Publicado: (2021)

Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population
por: Hachulla, Eric, et al.
Publicado: (2015)

Renal Crisis as the Initial Manifestation of Scleroderma
por: Gandhi, Ronak, et al.
Publicado: (2022)

Scleroderma Renal Crisis: A Pathology Perspective
por: Batal, Ibrahim, et al.
Publicado: (2010)

Scleroderma Renal Crisis in a Normotensive Patient
por: Asamoah-Odei, Efua
Publicado: (2016)

Patient with ankylosing spondylitis and scleroderma renal crisis
por: Venetsanopoulou, Aliki I., et al.
Publicado: (2018)

Tozinameran: Scleroderma renal crisis: case report
Publicado: (2022)

181 Scleroderma Renal Crisis and COVID—Is There an Association?
Publicado: (2022)

Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis
por: Sobanski, Vincent, et al.
Publicado: (2019)

Renal Disease and Systemic Sclerosis: an Update on Scleroderma Renal Crisis
por: Cole, Alice, et al.
Publicado: (2022)

Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database
por: Allanore, Yannick, et al.
Publicado: (2020)

Complement activation and effect of eculizumab in scleroderma renal crisis
por: Devresse, Arnaud, et al.
Publicado: (2016)

Diffused Alveolar Hemorrhage in the Setting of Scleroderma Renal Crisis
por: Henao, Jose, et al.
Publicado: (2019)

Systemic sclerosis medications and risk of scleroderma renal crisis
por: Gordon, S. M., et al.
Publicado: (2019)

Scleroderma Renal Crisis With Thrombotic Microangiopathy Treated With Eculizumab
por: Saba, Ludovic, et al.
Publicado: (2022)

Scleroderma renal crisis with posterior reversible encephalopathy syndrome
por: Wang, Gang, et al.
Publicado: (2023)

Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort
por: Kuster, Simon, et al.
Publicado: (2022)

A 45-Year-Old Man with Scleroderma Renal Crisis Associated with a History of Systemic Sclerosis Sine Scleroderma
por: Hansrivijit, Panupong, et al.
Publicado: (2020)

The need for a holistic approach for SSc-ILD – achievements and ambiguity in a devastating disease
por: Hoffmann-Vold, Anna-Maria, et al.
Publicado: (2020)

Paclitaxel-induced diffuse scleroderma with possible scleroderma-renal crisis: a case report and literature review of taxanes-induced scleroderma
por: Ketpueak, Thanika, et al.
Publicado: (2022)

Autoantibodies from Patients with Scleroderma Renal Crisis Promote PAR-1 Receptor Activation and IL-6 Production in Endothelial Cells
por: Simon, Michèle, et al.
Publicado: (2021)

Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical features
por: Hoffmann-Vold, Anna-Maria, et al.
Publicado: (2019)

Scleroderma Renal Crisis Associated With Microangiopathic Hemolytic Anemia in a Patient With Seronegative Scleroderma and Monoclonal Gammopathy
por: Riley, Mark, et al.
Publicado: (2022)

Scleroderma renal crisis in tropical region: two senegalese cases
por: Cisse, Mouhamadou Moustapha, et al.
Publicado: (2015)

Anticentromere Antibody-positive Scleroderma Renal Crisis Requiring Dialysis
por: Ubukata, Masamitsu, et al.
Publicado: (2018)

Endothelial lesion and complement activation in patients with Scleroderma Renal Crisis
por: Pérez, Ney Arencibia, et al.
Publicado: (2019)

A Critical Care Standpoint in the Diagnosis of Scleroderma Renal Crisis
por: Tagliaferri, Ariana, et al.
Publicado: (2023)

An Acute Large Pericardial Effusion in a Scleroderma Renal Crisis
por: Ghallab, Muhammad, et al.
Publicado: (2023)

Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China
por: Hu, Shasha, et al.
Publicado: (2018)

Scleroderma Renal Crisis in a Systemic Sclerosis With Anti-PM/Scl Antibodies
por: Jacquier, Marine, et al.
Publicado: (2019)

Natural variability in the disease course of SSc-ILD: implications for treatment
por: Vonk, Madelon C., et al.
Publicado: (2021)

Scleroderma Renal Crisis Debute with Thrombotic Microangiopathy: A Successful Case Treated with Eculizumab
por: Uriarte, Maite Hurtado, et al.
Publicado: (2018)

Scleroderma Renal Crisis Complicated with Thrombotic Microangiopathy Triggered by Influenza B Virus Infection
por: Shimizu, Toshimasa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gqgutnd70ikj3fgfj6hhupi2b0